Propranolol
| Propranolol | |
|---|---|
| Salts [] | |
|---|---|
| Propranolol hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 259.34 g/mol [1] |
| Melting point | 96 °C [1] |
| Solubility | 0.0617 mg/L at 25 °C [1] |
| Predicted LogP | 3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H21NO2 [1] |
| IUPAC name | 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol [1] |
| SMILES | CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O [1] |
| InChI | InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3 [1] |
| InChIKey | AQHHHDLHHXJYJD-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | ~4 hours (range 3 – 8 hours) |
| Duration of action | 12 hours |
| Dosing[] |
|---|
| Oral [] | |
|---|---|
| Light | ≤ 17.5 mg(1x - 50%) |
| Common | 17.5 - 25 mg |
| Strong | 25 - 32.5 mg |
| Heavy | 32.5 - 37 mg |
| Extreme | 37 mg +(1x - 50%) |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Propranolol (also known as Propranolol, Propanolol, β-Propranolol, βlong, Euprovasin, Proprasylyt, Reducor, Propanalol, Anapriline or propranololo)
Chemistry
Salts []
Propranolol is typically found in the form of its hydrochloride salt.
Stereochemistry []
Propranolol is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Pharmacology
ATC Classification
In the cardiovascular system (C) propranolol actsMetabolism
Interactions
| CYP2D6 | induction / inhibition |
|---|---|
| CYP2C19 | induction / inhibition |
| CYP1A2 | induction / inhibition |
Subjective effects []
| bonzi / Propranolol [] | |
|---|---|
Legal status []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4946, Propranolol. Accessed April 16, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4946
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Propranolol. UNII: 9Y8NXQ24VQ. Global Substance Registration System. Accessed April 16, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9Y8NXQ24VQ
Inderal (propranolol hydrochloride) Tablets. Accessed April 16, 2026. https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=298083
Inderal LA- propranolol hydrochloride capsule, extended release. August 1, 2024. Accessed April 16, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=35d28979-36b1-4630-b85e-a44e0a443734
Inderal XL- propranolol hydrochloride capsule, extended release. March 20, 2024. Accessed April 16, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac196ff5-9215-402b-bc57-69aa87f8bade
Hemangeol- propranolol hydrochloride solution. December 17, 2025. Accessed April 16, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6f9dd2a-632b-87eb-70f0-b2064d7ed48a